New website launched Our new website is here. Find out more
Skip to main content Skip to side navigation
  • Chin PKL, Chew-Harris JSC, Florkowski CM, Begg EJ. The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance. Br J Clin Pharmacol 2015; 79(2), 268-77 [Abstract]
  • Chinnaratha MA, Chaudhary S, Doogue M, McCormick RJ, et al. Prevalence of hepatic osteodystrophy and vitamin D deficiency in cirrhosis. Intern Med J 2015; [Abstract]
  • Doogue M, Jones A. Clinical pharmacology and toxicology. Essentials of Internal Medicine (book) 2015; 3rd edition, 27-55 [Chapter]
  • Chew-Harris JSC, Chin PKL, Florkowski CM, George P, Endre Z. Removal of body surface area normalisation improves raw-measured GFR estimation by the CKD-EPI equation and drug dosing in the obese. Intern Med J 2015 (online) [Abstract]
  • Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O'Dea H, Stranks SN, Burt MG, Doogue MP. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab 2015; 10.1210jc 2015-2660 [Abstract]
  • Doecke JD, Simms LA, Roberts RL, Barclay ML, et al. Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's disease. J Gastroenterol Hepatol 2015; 30, 299-307 [Abstract]
  • Buffery PJ, Strother RM. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations. NZ Med J 2015; 128(1416), 66-74 [Abstract]
  • Roberts RL, Barclay ML. Update on thiopurine pharmacogenetics in inflammatory bowel disease. Pharmacogenomics 2015; 16(8), 891-903 [Abstract]
  • Chew-Harris JSC, Chin PKL, Florkowski CM, George PM, Endre ZH. Accounting for individual body surface area does not improve estimation of absolute GFR using the CKD-EPI equation. Pathology 2015; 47, S82 [Abstract]
  • Hock BD, Stamp LK, Hatman MW, Barclay ML, et al. Development of an ELISA based competitive binding assay for the analysis of drug concentration and anti-drug antibody levels in patients receiving adalimumab or infliximab. Ther Drug Monit 2015;  [Abstract]
  • Chua EW, Cree S, Barclay Ml, Doudney K, Lehnert K, et al. Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers. Pharmacogenomics J 2015; 1-8 [Abstract]
  • Plajer SM, Chin PKL. Vella-Brincat JWA, Buffery PJ, Begg EJ. Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin. Ther Drug Monit 2015; 37(1), 98-103 [Abstract]
  • Chin PK. Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants? Semin Thromb Hemost 2015; 41(2), 195-207 [Abstract]
  • Clark K, Quinn SI, Doogue M, Sanderson C, et al. Routine prescribing of gabapentin or pregabalin in supportive and palliative care: what are the comparative performances of the medications in a palliative care population? Support Care Cancer 2015; 23(9), 2517-20 [Abstract]
  • Saffian SM, Zhang M, Chin PKL, Jensen BP. Quantification of dabigatran and indirect quantification of dabigatran acylglucuronides in human plasma by LC-Ms/MS. Bioanalysis 2015; 7(8), 957-66 [Abstract]
Back to top